David W. Meline
Net Worth
Last updated:
What is David W. Meline net worth?
The estimated net worth of Mr. David W. Meline is at least $3,024,836 as of 10 Aug 2022. He owns shares worth $79,282 as insider, has earned $147,694 from insider trading and has received compensation worth at least $2,797,860 in Moderna, Inc..
What is the salary of David W. Meline?
Mr. David W. Meline salary is $932,620 per year as Chief Financial Officer & Principal Accounting Officer in Moderna, Inc..
How old is David W. Meline?
Mr. David W. Meline is 68 years old, born in 1957.
What stocks does David W. Meline currently own?
As insider, Mr. David W. Meline owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Moderna, Inc. (MRNA) | Chief Financial Officer & Principal Accounting Officer | 2,857 | $27.75 | $79,282 |
What does Moderna, Inc. do?
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus vaccines; and public health vaccines consists of Zika and Nipah vaccines. The company also offers systemic secreted and cell surface therapeutics; cancer vaccines, such as personalized cancer, KRAS, and checkpoint vaccines; intratumoral immuno-oncology products; localized regenerative, systemic intracellular, and inhaled pulmonary therapeutics. It has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
David W. Meline insider trading
Moderna, Inc.
Mr. David W. Meline has made 3 insider trades in 2022, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 1,392 units of MRNA stock on 9 Feb 2022. As of 10 Aug 2022 he still owns at least 2,857 units of MRNA stock.
Moderna key executives
Moderna, Inc. executives and other stock owners filed with the SEC:
- Dr. Noubar B. Afeyan Ph.D. (62) Co-Founder, Independent Non Executive Chairman & Member of Technology Advisory Board
- Dr. Stephen Hoge (49) Pres
- Mr. David W. Meline (68) Chief Financial Officer & Principal Accounting Officer
- Mr. Juan Andres (60) Chief Technical Operations & Quality Officer
- Mr. Stephane Bancel (52) Chief Executive Officer & Director